ARCHIVES

Anamorelin Increases Body Mass In Two Global Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

DCE Reorganization Planned To Stem Departures, Stabilize

March 24, 1995

NCAB Asks NCI To Delay Proposed change In Breast Cancer Screening Guidelines

November 26, 1993

NCI Advisory Group, Other Cancer Meetings for Oct., Nov., Future

September 29, 1989

Vitamin D Not Associated With Risk For Less Common Cancers, Study Finds

July 30, 2010

Frelick To Receive ACCC Annual Award Will Leave NCI In July

March 6, 1987

In Brief : Three Named To Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

July 11, 2014